Cytokinetics To Announce First Quarter Results On April 27, 2017 Post author:Sam Post published:April 13, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017 <b>Gendius</b> Announces Funding From <b>Catapult Ventures</b> To Launch Innovative Digital Health Platform For Patients Living With Diabetes October 5, 2017 Bone Therapeutics Announces H1 Results For 2017 August 30, 2017
Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017
<b>Gendius</b> Announces Funding From <b>Catapult Ventures</b> To Launch Innovative Digital Health Platform For Patients Living With Diabetes October 5, 2017